Parotid gland non-Hodgkin lymphoma in primary Sjögren syndrome
Identifieur interne : 001743 ( Istex/Corpus ); précédent : 001742; suivant : 001744Parotid gland non-Hodgkin lymphoma in primary Sjögren syndrome
Auteurs : Thierry ZenoneSource :
- Rheumatology International [ 0172-8172 ] ; 2012-05-01.
English descriptors
- KwdEn :
Abstract
Abstract: The risk of malignant non-Hodgkin lymphoma is increased in primary Sjögren syndrome. In the literature, most studies evaluating this risk were conducted in tertiary reference university hospital. So, selection bias in series exists, in particular selection of the most severe cases in tertiary reference university care centers. Some studies had also a selection bias because patients were hospitalized (data were obtained from hospital discharge registries) and therefore the more severe cases were considered. Between October 1999 and November 2009, 109 adult patients were admitted to our department of internal medicine (non-university hospital, secondary level of the healthcare system, hospitalized patients and outpatient) with diagnosis of primary Sjögren syndrome. Two cases of parotid gland lymphoma occurred during the period of follow-up. No other lymphoma was detected. In this study, clinically identifiable parotid gland non-Hodgkin lymphoma occurs in 1.8% of patients with primary Sjögren syndrome. Because most non-Hodgkin lymphoma initially involves the neck organs, meticulous imaging studies mainly focused on the cervical regions are recommended in the follow-up of patients with primary Sjögren syndrome. Patients whose main complaint is persistent parotid gland swelling may have a parotid biopsy in order to diagnose non-Hodgkin lymphoma.
Url:
DOI: 10.1007/s00296-011-1851-9
Links to Exploration step
ISTEX:78C42ABD28CC8930F61B200EEC5CF8602558B2A6Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Parotid gland non-Hodgkin lymphoma in primary Sjögren syndrome</title><author><name sortKey="Zenone, Thierry" sort="Zenone, Thierry" uniqKey="Zenone T" first="Thierry" last="Zenone">Thierry Zenone</name><affiliation><mods:affiliation>Department of Internal Medicine, Centre Hospitalier, 179 boulevard Marechal Juin, 26953, Valence cedex 9, France</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: tzenone@ch-valence.fr</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:78C42ABD28CC8930F61B200EEC5CF8602558B2A6</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1007/s00296-011-1851-9</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-3N3G7JK5-X/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001743</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001743</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Parotid gland non-Hodgkin lymphoma in primary Sjögren syndrome</title><author><name sortKey="Zenone, Thierry" sort="Zenone, Thierry" uniqKey="Zenone T" first="Thierry" last="Zenone">Thierry Zenone</name><affiliation><mods:affiliation>Department of Internal Medicine, Centre Hospitalier, 179 boulevard Marechal Juin, 26953, Valence cedex 9, France</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: tzenone@ch-valence.fr</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Rheumatology International</title><title level="j" type="sub">Clinical and Experimental Investigations</title><title level="j" type="abbrev">Rheumatol Int</title><idno type="ISSN">0172-8172</idno><idno type="eISSN">1437-160X</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>Berlin/Heidelberg</pubPlace><date type="published" when="2012-05-01">2012-05-01</date><biblScope unit="volume">32</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="1387">1387</biblScope><biblScope unit="page" to="1390">1390</biblScope></imprint><idno type="ISSN">0172-8172</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0172-8172</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Lymphoma</term><term>Parotid biopsy</term><term>Sjögren syndrome</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: The risk of malignant non-Hodgkin lymphoma is increased in primary Sjögren syndrome. In the literature, most studies evaluating this risk were conducted in tertiary reference university hospital. So, selection bias in series exists, in particular selection of the most severe cases in tertiary reference university care centers. Some studies had also a selection bias because patients were hospitalized (data were obtained from hospital discharge registries) and therefore the more severe cases were considered. Between October 1999 and November 2009, 109 adult patients were admitted to our department of internal medicine (non-university hospital, secondary level of the healthcare system, hospitalized patients and outpatient) with diagnosis of primary Sjögren syndrome. Two cases of parotid gland lymphoma occurred during the period of follow-up. No other lymphoma was detected. In this study, clinically identifiable parotid gland non-Hodgkin lymphoma occurs in 1.8% of patients with primary Sjögren syndrome. Because most non-Hodgkin lymphoma initially involves the neck organs, meticulous imaging studies mainly focused on the cervical regions are recommended in the follow-up of patients with primary Sjögren syndrome. Patients whose main complaint is persistent parotid gland swelling may have a parotid biopsy in order to diagnose non-Hodgkin lymphoma.</div></front></TEI><istex><corpusName>springer-journals</corpusName><author><json:item><name>Thierry Zenone</name><affiliations><json:string>Department of Internal Medicine, Centre Hospitalier, 179 boulevard Marechal Juin, 26953, Valence cedex 9, France</json:string><json:string>E-mail: tzenone@ch-valence.fr</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Lymphoma</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Sjögren syndrome</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Parotid biopsy</value></json:item></subject><articleId><json:string>1851</json:string><json:string>s00296-011-1851-9</json:string></articleId><arkIstex>ark:/67375/VQC-3N3G7JK5-X</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>BriefCommunication</json:string></originalGenre><abstract>Abstract: The risk of malignant non-Hodgkin lymphoma is increased in primary Sjögren syndrome. In the literature, most studies evaluating this risk were conducted in tertiary reference university hospital. So, selection bias in series exists, in particular selection of the most severe cases in tertiary reference university care centers. Some studies had also a selection bias because patients were hospitalized (data were obtained from hospital discharge registries) and therefore the more severe cases were considered. Between October 1999 and November 2009, 109 adult patients were admitted to our department of internal medicine (non-university hospital, secondary level of the healthcare system, hospitalized patients and outpatient) with diagnosis of primary Sjögren syndrome. Two cases of parotid gland lymphoma occurred during the period of follow-up. No other lymphoma was detected. In this study, clinically identifiable parotid gland non-Hodgkin lymphoma occurs in 1.8% of patients with primary Sjögren syndrome. Because most non-Hodgkin lymphoma initially involves the neck organs, meticulous imaging studies mainly focused on the cervical regions are recommended in the follow-up of patients with primary Sjögren syndrome. Patients whose main complaint is persistent parotid gland swelling may have a parotid biopsy in order to diagnose non-Hodgkin lymphoma.</abstract><qualityIndicators><refBibsNative>false</refBibsNative><abstractWordCount>193</abstractWordCount><abstractCharCount>1372</abstractCharCount><keywordCount>3</keywordCount><score>6.031</score><pdfWordCount>1715</pdfWordCount><pdfCharCount>11123</pdfCharCount><pdfVersion>1.4</pdfVersion><pdfPageCount>4</pdfPageCount><pdfPageSize>595 x 791 pts</pdfPageSize></qualityIndicators><title>Parotid gland non-Hodgkin lymphoma in primary Sjögren syndrome</title><genre><json:string>brief-communication</json:string></genre><host><title>Rheumatology International</title><language><json:string>unknown</json:string></language><publicationDate>2012</publicationDate><copyrightDate>2012</copyrightDate><issn><json:string>0172-8172</json:string></issn><eissn><json:string>1437-160X</json:string></eissn><journalId><json:string>296</json:string></journalId><volume>32</volume><issue>5</issue><pages><first>1387</first><last>1390</last></pages><genre><json:string>journal</json:string></genre><subject><json:item><value>Rheumatology</value></json:item></subject></host><ark><json:string>ark:/67375/VQC-3N3G7JK5-X</json:string></ark><publicationDate>2012</publicationDate><copyrightDate>2011</copyrightDate><doi><json:string>10.1007/s00296-011-1851-9</json:string></doi><id>78C42ABD28CC8930F61B200EEC5CF8602558B2A6</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/VQC-3N3G7JK5-X/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/VQC-3N3G7JK5-X/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/VQC-3N3G7JK5-X/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Parotid gland non-Hodgkin lymphoma in primary Sjögren syndrome</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher scheme="https://scientific-publisher.data.istex.fr">Springer-Verlag</publisher><pubPlace>Berlin/Heidelberg</pubPlace><availability><licence><p>Springer-Verlag, 2011</p></licence><p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-3XSW68JL-F">springer</p></availability><date>2010-10-28</date></publicationStmt><notesStmt><note type="brief-communication" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-S9SX2MFS-0">brief-communication</note><note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note><note>Short Communication</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Parotid gland non-Hodgkin lymphoma in primary Sjögren syndrome</title><author xml:id="author-0000" corresp="yes"><persName><forename type="first">Thierry</forename><surname>Zenone</surname></persName><email>tzenone@ch-valence.fr</email><affiliation>Department of Internal Medicine, Centre Hospitalier, 179 boulevard Marechal Juin, 26953, Valence cedex 9, France</affiliation></author><idno type="istex">78C42ABD28CC8930F61B200EEC5CF8602558B2A6</idno><idno type="ark">ark:/67375/VQC-3N3G7JK5-X</idno><idno type="DOI">10.1007/s00296-011-1851-9</idno><idno type="article-id">1851</idno><idno type="article-id">s00296-011-1851-9</idno></analytic><monogr><title level="j">Rheumatology International</title><title level="j" type="sub">Clinical and Experimental Investigations</title><title level="j" type="abbrev">Rheumatol Int</title><idno type="pISSN">0172-8172</idno><idno type="eISSN">1437-160X</idno><idno type="journal-ID">true</idno><idno type="issue-article-count">66</idno><idno type="volume-issue-count">12</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>Berlin/Heidelberg</pubPlace><date type="published" when="2012-05-01"></date><biblScope unit="volume">32</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="1387">1387</biblScope><biblScope unit="page" to="1390">1390</biblScope></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2010-10-28</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Abstract: The risk of malignant non-Hodgkin lymphoma is increased in primary Sjögren syndrome. In the literature, most studies evaluating this risk were conducted in tertiary reference university hospital. So, selection bias in series exists, in particular selection of the most severe cases in tertiary reference university care centers. Some studies had also a selection bias because patients were hospitalized (data were obtained from hospital discharge registries) and therefore the more severe cases were considered. Between October 1999 and November 2009, 109 adult patients were admitted to our department of internal medicine (non-university hospital, secondary level of the healthcare system, hospitalized patients and outpatient) with diagnosis of primary Sjögren syndrome. Two cases of parotid gland lymphoma occurred during the period of follow-up. No other lymphoma was detected. In this study, clinically identifiable parotid gland non-Hodgkin lymphoma occurs in 1.8% of patients with primary Sjögren syndrome. Because most non-Hodgkin lymphoma initially involves the neck organs, meticulous imaging studies mainly focused on the cervical regions are recommended in the follow-up of patients with primary Sjögren syndrome. Patients whose main complaint is persistent parotid gland swelling may have a parotid biopsy in order to diagnose non-Hodgkin lymphoma.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>Lymphoma</term></item><item><term>Sjögren syndrome</term></item><item><term>Parotid biopsy</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>Medicine & Public Health</head><item><term>Rheumatology</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2010-10-28">Created</change><change when="2012-05-01">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/VQC-3N3G7JK5-X/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="corpus springer-journals not found" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0" encoding="UTF-8"</istex:xmlDeclaration><istex:docType PUBLIC="-//Springer-Verlag//DTD A++ V2.4//EN" URI="http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd" name="istex:docType"></istex:docType><istex:document><Publisher><PublisherInfo><PublisherName>Springer-Verlag</PublisherName><PublisherLocation>Berlin/Heidelberg</PublisherLocation></PublisherInfo><Journal OutputMedium="All"><JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered"><JournalID>296</JournalID><JournalPrintISSN>0172-8172</JournalPrintISSN><JournalElectronicISSN>1437-160X</JournalElectronicISSN><JournalTitle>Rheumatology International</JournalTitle><JournalSubTitle>Clinical and Experimental Investigations</JournalSubTitle><JournalAbbreviatedTitle>Rheumatol Int</JournalAbbreviatedTitle><JournalSubjectGroup><JournalSubject Type="Primary">Medicine & Public Health</JournalSubject><JournalSubject Type="Secondary">Rheumatology</JournalSubject></JournalSubjectGroup></JournalInfo><Volume OutputMedium="All"><VolumeInfo TocLevels="0" VolumeType="Regular"><VolumeIDStart>32</VolumeIDStart><VolumeIDEnd>32</VolumeIDEnd><VolumeIssueCount>12</VolumeIssueCount></VolumeInfo><Issue IssueType="Regular" OutputMedium="All"><IssueInfo IssueType="Regular" TocLevels="0"><IssueIDStart>5</IssueIDStart><IssueIDEnd>5</IssueIDEnd><IssueArticleCount>66</IssueArticleCount><IssueHistory><OnlineDate><Year>2012</Year><Month>4</Month><Day>25</Day></OnlineDate><PrintDate><Year>2012</Year><Month>4</Month><Day>24</Day></PrintDate><CoverDate><Year>2012</Year><Month>5</Month></CoverDate><PricelistYear>2012</PricelistYear></IssueHistory><IssueCopyright><CopyrightHolderName>Springer-Verlag</CopyrightHolderName><CopyrightYear>2012</CopyrightYear></IssueCopyright></IssueInfo><Article ID="s00296-011-1851-9" OutputMedium="All"><ArticleInfo ArticleType="BriefCommunication" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0"><ArticleID>1851</ArticleID><ArticleDOI>10.1007/s00296-011-1851-9</ArticleDOI><ArticleSequenceNumber>45</ArticleSequenceNumber><ArticleTitle Language="En" OutputMedium="All">Parotid gland non-Hodgkin lymphoma in primary Sjögren syndrome</ArticleTitle><ArticleCategory>Short Communication</ArticleCategory><ArticleFirstPage>1387</ArticleFirstPage><ArticleLastPage>1390</ArticleLastPage><ArticleHistory><RegistrationDate><Year>2011</Year><Month>3</Month><Day>8</Day></RegistrationDate><Received><Year>2010</Year><Month>10</Month><Day>28</Day></Received><Accepted><Year>2011</Year><Month>2</Month><Day>18</Day></Accepted><OnlineDate><Year>2011</Year><Month>3</Month><Day>23</Day></OnlineDate></ArticleHistory><ArticleCopyright><CopyrightHolderName>Springer-Verlag</CopyrightHolderName><CopyrightYear>2011</CopyrightYear></ArticleCopyright><ArticleGrants Type="Regular"><MetadataGrant Grant="OpenAccess"></MetadataGrant><AbstractGrant Grant="OpenAccess"></AbstractGrant><BodyPDFGrant Grant="Restricted"></BodyPDFGrant><BodyHTMLGrant Grant="Restricted"></BodyHTMLGrant><BibliographyGrant Grant="Restricted"></BibliographyGrant><ESMGrant Grant="Restricted"></ESMGrant></ArticleGrants></ArticleInfo><ArticleHeader><AuthorGroup><Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1"><AuthorName DisplayOrder="Western"><GivenName>Thierry</GivenName><FamilyName>Zenone</FamilyName></AuthorName><Contact><Phone>+33-475757539</Phone><Fax>+33-475757275</Fax><Email>tzenone@ch-valence.fr</Email></Contact></Author><Affiliation ID="Aff1"><OrgDivision>Department of Internal Medicine</OrgDivision><OrgName>Centre Hospitalier</OrgName><OrgAddress><Street>179 boulevard Marechal Juin</Street><Postcode>26953</Postcode><City>Valence cedex 9</City><Country Code="FR">France</Country></OrgAddress></Affiliation></AuthorGroup><Abstract ID="Abs1" Language="En" OutputMedium="All"><Heading>Abstract</Heading><Para>The risk of malignant non-Hodgkin lymphoma is increased in primary Sjögren syndrome. In the literature, most studies evaluating this risk were conducted in tertiary reference university hospital. So, selection bias in series exists, in particular selection of the most severe cases in tertiary reference university care centers. Some studies had also a selection bias because patients were hospitalized (data were obtained from hospital discharge registries) and therefore the more severe cases were considered. Between October 1999 and November 2009, 109 adult patients were admitted to our department of internal medicine (non-university hospital, secondary level of the healthcare system, hospitalized patients and outpatient) with diagnosis of primary Sjögren syndrome. Two cases of parotid gland lymphoma occurred during the period of follow-up. No other lymphoma was detected. In this study, clinically identifiable parotid gland non-Hodgkin lymphoma occurs in 1.8% of patients with primary Sjögren syndrome. Because most non-Hodgkin lymphoma initially involves the neck organs, meticulous imaging studies mainly focused on the cervical regions are recommended in the follow-up of patients with primary Sjögren syndrome. Patients whose main complaint is persistent parotid gland swelling may have a parotid biopsy in order to diagnose non-Hodgkin lymphoma.</Para></Abstract><KeywordGroup Language="En" OutputMedium="All"><Heading>Keywords</Heading><Keyword>Lymphoma</Keyword><Keyword>Sjögren syndrome</Keyword><Keyword>Parotid biopsy</Keyword></KeywordGroup></ArticleHeader><NoBody></NoBody></Article></Issue></Volume></Journal></Publisher></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Parotid gland non-Hodgkin lymphoma in primary Sjögren syndrome</title></titleInfo><titleInfo type="alternative" contentType="CDATA"><title>Parotid gland non-Hodgkin lymphoma in primary Sjögren syndrome</title></titleInfo><name type="personal" displayLabel="corresp"><namePart type="given">Thierry</namePart><namePart type="family">Zenone</namePart><affiliation>Department of Internal Medicine, Centre Hospitalier, 179 boulevard Marechal Juin, 26953, Valence cedex 9, France</affiliation><affiliation>E-mail: tzenone@ch-valence.fr</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="brief-communication" displayLabel="BriefCommunication" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-S9SX2MFS-0">brief-communication</genre><originInfo><publisher>Springer-Verlag</publisher><place><placeTerm type="text">Berlin/Heidelberg</placeTerm></place><dateCreated encoding="w3cdtf">2010-10-28</dateCreated><dateIssued encoding="w3cdtf">2012-05-01</dateIssued><copyrightDate encoding="w3cdtf">2011</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><abstract lang="en">Abstract: The risk of malignant non-Hodgkin lymphoma is increased in primary Sjögren syndrome. In the literature, most studies evaluating this risk were conducted in tertiary reference university hospital. So, selection bias in series exists, in particular selection of the most severe cases in tertiary reference university care centers. Some studies had also a selection bias because patients were hospitalized (data were obtained from hospital discharge registries) and therefore the more severe cases were considered. Between October 1999 and November 2009, 109 adult patients were admitted to our department of internal medicine (non-university hospital, secondary level of the healthcare system, hospitalized patients and outpatient) with diagnosis of primary Sjögren syndrome. Two cases of parotid gland lymphoma occurred during the period of follow-up. No other lymphoma was detected. In this study, clinically identifiable parotid gland non-Hodgkin lymphoma occurs in 1.8% of patients with primary Sjögren syndrome. Because most non-Hodgkin lymphoma initially involves the neck organs, meticulous imaging studies mainly focused on the cervical regions are recommended in the follow-up of patients with primary Sjögren syndrome. Patients whose main complaint is persistent parotid gland swelling may have a parotid biopsy in order to diagnose non-Hodgkin lymphoma.</abstract><note>Short Communication</note><subject lang="en"><genre>Keywords</genre><topic>Lymphoma</topic><topic>Sjögren syndrome</topic><topic>Parotid biopsy</topic></subject><relatedItem type="host"><titleInfo><title>Rheumatology International</title><subTitle>Clinical and Experimental Investigations</subTitle></titleInfo><titleInfo type="abbreviated"><title>Rheumatol Int</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><originInfo><publisher>Springer</publisher><dateIssued encoding="w3cdtf">2012-04-25</dateIssued><copyrightDate encoding="w3cdtf">2012</copyrightDate></originInfo><subject><genre>Medicine & Public Health</genre><topic>Rheumatology</topic></subject><identifier type="ISSN">0172-8172</identifier><identifier type="eISSN">1437-160X</identifier><identifier type="JournalID">296</identifier><identifier type="IssueArticleCount">66</identifier><identifier type="VolumeIssueCount">12</identifier><part><date>2012</date><detail type="volume"><number>32</number><caption>vol.</caption></detail><detail type="issue"><number>5</number><caption>no.</caption></detail><extent unit="pages"><start>1387</start><end>1390</end></extent></part><recordInfo><recordOrigin>Springer-Verlag, 2012</recordOrigin></recordInfo></relatedItem><identifier type="istex">78C42ABD28CC8930F61B200EEC5CF8602558B2A6</identifier><identifier type="ark">ark:/67375/VQC-3N3G7JK5-X</identifier><identifier type="DOI">10.1007/s00296-011-1851-9</identifier><identifier type="ArticleID">1851</identifier><identifier type="ArticleID">s00296-011-1851-9</identifier><accessCondition type="use and reproduction" contentType="copyright">Springer-Verlag, 2011</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-3XSW68JL-F">springer</recordContentSource><recordOrigin>Springer-Verlag, 2011</recordOrigin></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/VQC-3N3G7JK5-X/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001743 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001743 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:78C42ABD28CC8930F61B200EEC5CF8602558B2A6
|texte= Parotid gland non-Hodgkin lymphoma in primary Sjögren syndrome
}}
| This area was generated with Dilib version V0.6.33. |  |